Who owns AKARI THERAPEUTICS PLC?
- Ticker: AKTX
- CUSIP Number: 00972g405
Tip: Access positions for across all investors
Analyze quarterly positions in Akari Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Akari Therapeutics stock
Who bought or sold AKARI THERAPEUTICS PLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 100k | $1.0M | 100% | Jun 2026 |
|
| Cresset Asset Management | 21k | $211k | 0% | Jun 2026 |
|
| Jane Street | 16k | $158k | 100% | Jun 2026 |
|
| Hrt Financial | 14k | $140k | 100% | Jun 2026 |
|
| Citadel Advisors | 10k | $103k | 100% | Jun 2026 |
|
| IFP Advisors | 181.00 | $1.9k | 0% | Jun 2026 |
|
| SBI Securities | 14.00 | $143.000200 | 180% | Jun 2026 |
|
| Caitong International Asset Management | 8.00 | $82.000000 | 100% | Jun 2026 |
|
| Northwestern Mutual Wealth Management Company | 7.00 | $71.999900 | 100% | Jun 2026 |
|
| Truvestments Capital | 1.00 | $10.000000 | 0% | Jun 2026 |
|
| Morgan Stanley | 1.00 | $5.000000 | 100% | Mar 2026 |
|
Who sold out of Akari Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Armistice Capital | Mar 2026 | 39k | $200k |